A Study of DM002 in Patients With Advanced Solid Tumors

NCT06751329 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Neoplasms
Prostatic Neoplasms
Endometrial Neoplasms
Colorectal Neoplasms
Solid Carcinoma

Interventions

DRUG: DM002

Sponsor

Xadcera Biopharmaceutical (Suzhou) Co., Ltd.